Search results for:

conjugated estrogens IV

conjugated estrogens IV
Brand names: Premarin Intravenous
Form Strength
POWDER FOR INJECTION, INJECTABLE 25 mg


Medication comments:

Refrigerator item 

USP <800> Hazardous Drug Assessment of Risk (AOR)
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances.
The following outlines must be followed.
generic (Brand) Route
[Packaging: Manufacturer ⇒ Dispense]
Activities
estrogens, conjugated (Premarin) IV
[n/a]
Stock @ IDBH? N
NIOSH Table 1A
Pharmacy:
Receiving / Storage / Preparation


Exposure Risk: low
• Handling/preparation PPE Requirements: Single CX glove, gown
• Receiving from Distributor: Standard
• Pharmacy Storage Area: IV (fridge)
• Packaging/Reconstitution Location: n/a
• Compounding (Non-Sterile/Sterile) Location: Positive pressure room
• Omnicell Load: No
Transport • Transport (dose is placed inside a plastic sealable bag): Standard
Nursing:
Storage / Administration


Exposure Risk: low
• Handling/administration PPE Requirements: Single pair of CX approved gloves
Wash hands after handling
• Storage of Finished dose in Nursing Area/Procedural Area: Patient Med Drawer
• Signage on Patient Door Required: No
• Manipulation of Dosage Form: n/a
• Special Manipulation for Administration: n/a
Disposal / Spills • Disposal of Drug Waste: Full-  black bin 
Trace/packaging-  yellow bin 
• Disposol of Used PPE: trash bin (inside plastic bag)
• Spill management: Wear CX gloves
items used to clean up spill should be placed in a sealed bag and put in  blue bin 
NIOSH Supplemental Information: BBW for malignant neoplasms; increased risk of endometrial, ovarian and breast cancer; in laboratory studies, increased frequency of carcinomas of breast, uterus, cervix, vagina, testis, and liver; present in breast milk. Listed by NTP and IARC. Not listed by OSHA.
Take up mechanically and collect in suitable container for disposal. Clean contaminated surface thoroughly.
Reason for exemption of USP<800> Containment Requirements: Pregnancy Category X. Risks are related to systemic absorption.

Last updated: May. 22, 2025



Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.